Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct…
By G. Meyer, K. Wollert, J. Lotz, J. Steffens, P. Lippolt, S. Fichtner, H. Hecker, A. Schaefer, L. Arseniev, B. Hertenstein and 2 more. Circulation, 2006
1,058 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Genetics, Surgery
View Paper: https://www.semanticscholar.org/paper/623f21eb460ea7a4afb4418da5d8e08c38916ddc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Genetics
Citations in the corpus
- Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. (2007, result): “Although the Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) trial showed persistent benefits after 12 months of BMC and circulating progenitor cell therapy,(43) a longer follow-up of 18 months failed to demonstrate statistically signific”
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity (2009, methodology): “The protocol for cine-MRI and tagging-MRI has been described before (3).”